RT Journal Article SR Electronic T1 Antiseptic-Mediated Colloid Labeling as a Potential Source of Abnormal Liver and Spleen Uptake with 99mTc-Dimercaptosuccinic Acid JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP jnmt.120.258020 DO 10.2967/jnmt.120.258020 A1 Veronica Krull A1 Madison R. Kocher A1 William J Rieter YR 2021 UL http://tech.snmjournals.org/content/early/2021/03/12/jnmt.120.258020.abstract AB Altered biodistribution can be a source of diagnostic error in the interpretation of nuclear medicine studies. We report a case of increased liver and spleen uptake with 99mTc-dimercaptosuccinic acid (DMSA) believed to be a result of chlorhexidine-mediated colloid labeling. This finding underscores the principle that certain constituents of antiseptics may adversely affect the purity of radiopharmaceuticals during their preparation.